# Early Commencement of Adjuvant Chemotherapy for Colon Cancer

Source: https://onco.cc/trials/nct01460589/  
OnCo record `nct01460589` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in colorectal cancer, run by Kyungpook National University Hospital, active but no longer recruiting.

## Summary

Early Commencement of Adjuvant Chemotherapy for Colon Cancer is a phase 3, randomised interventional study registered as NCT01460589 by Kyungpook National University Hospital, with a registry enrolment figure of 303 participants, started 2013-01-13 and due to reach its primary completion in 2024-06-19. Interventions recorded: timing to initiate the adjuvant FOLFOX chemotherapy. Conditions listed: Colon Cancer. Primary outcome: 3-year disease free survival rate. Colorectal eligibility wording from the registry: "* Rectal adenocarcinoma that were 15 cm or more from the anal verge". Sites: South Korea. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-24
- Also known as: ECTX
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT01460589
- Phase: 3
- Setting: Early Commencement of Adjuvant Chemotherapy for Stage III Colon Cancer: a Multicenter Randomized Trial
- Sponsor: Kyungpook National University Hospital
- Enrolled: 303

## Sources

- ClinicalTrials.gov NCT01460589: https://clinicaltrials.gov/study/NCT01460589

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/), [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct01460589.json